Transaction · 0002081681-26-000002
BIO BIO.BBIO-RAD LABORATORIES, INC.
Mehta Rajat
Mehta Rajat, EVP, GCO, reported a transaction classified as exercise at BIO-RAD LABORATORIES, INC. involving 1370.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1736.052000 shares. A 10b5-1 reference was not detected in the stored filing text.
exerciseSEC transaction code MEVP, GCO
- Trade date
- Sep 05, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BIO BIO.B price since this filing
Daily closing prices, with the filing date and available return windowsBIO BIO.B · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0002081681-26-000002 Bio-Rad A Common Stock
- Transaction date
- Sep 05, 2026 Filed Sep 09, 2026, 10:44 PM · 4d delay
- Shares
- 1,370 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 1,736.052 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score
+6 points
Compact filing score computed from stored Form 4 facts. Version v1.
Positive filing signal
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
EVP, GBL Commercial Operations
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2
Includes 57.9370, 53.0810 and 32.0340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2025, 03/31/2026 and 06/30/2026, respectively.
- F3
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F4
The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
- F5
The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Related transactions
Same SEC filing0 other transactions
Recent company activity
BIO BIO.B0 recent txs